882 - Efficacy and Safety of Anti-Interleukin-23 Therapy with Mirikizumab (LY3074828) in Patients with Moderate-To-Severe Ulcerative Colitis in a Phase 2 Study
| Autor: | Sandborn, William J., Ferrante, Marc, Bhandari, Bal R., D'Haens, Geert R., Berliba, Elina, Feagan, Brian G., Laskowski, Janelle, Friedrich, Stuart, Durante, Michael, Tuttle, Jay |
|---|---|
| Zdroj: | In Gastroenterology May 2018 154(6) Supplement 1:S |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|